Does the media favor GEHC or PHG?

In the previous week, GE HealthCare Technologies had 15 more articles in the media than Koninklijke Philips. MarketBeat recorded 18 mentions for GE HealthCare Technologies and 3 mentions for Koninklijke Philips. GE HealthCare Technologies' average media sentiment score of 0.95 beat Koninklijke Philips' score of 0.40 indicating that GE HealthCare Technologies is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment GE HealthCare Technologies 9 Very Positive mention(s) 3 Positive mention(s) 6 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Koninklijke Philips 0 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Which has higher earnings and valuation, MDLN or GEHC?

GE HealthCare Technologies has lower revenue, but higher earnings than Medline. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Medline $28.43B 1.55 N/A N/A N/A GE HealthCare Technologies $20.63B 1.43 $2.08B $4.18 15.47

Does the media refer more to MDLN or GEHC?

In the previous week, GE HealthCare Technologies had 8 more articles in the media than Medline. MarketBeat recorded 18 mentions for GE HealthCare Technologies and 10 mentions for Medline. GE HealthCare Technologies' average media sentiment score of 0.95 beat Medline's score of 0.22 indicating that GE HealthCare Technologies is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Medline 2 Very Positive mention(s) 3 Positive mention(s) 2 Neutral mention(s) 3 Negative mention(s) 0 Very Negative mention(s) Neutral GE HealthCare Technologies 9 Very Positive mention(s) 3 Positive mention(s) 6 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media prefer ZBH or GEHC?

In the previous week, GE HealthCare Technologies had 3 more articles in the media than Zimmer Biomet. MarketBeat recorded 18 mentions for GE HealthCare Technologies and 15 mentions for Zimmer Biomet. Zimmer Biomet's average media sentiment score of 1.20 beat GE HealthCare Technologies' score of 0.95 indicating that Zimmer Biomet is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Zimmer Biomet 11 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive GE HealthCare Technologies 9 Very Positive mention(s) 3 Positive mention(s) 6 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media refer more to SOLV or GEHC?

In the previous week, GE HealthCare Technologies had 12 more articles in the media than Solventum. MarketBeat recorded 18 mentions for GE HealthCare Technologies and 6 mentions for Solventum. GE HealthCare Technologies' average media sentiment score of 0.95 beat Solventum's score of -0.04 indicating that GE HealthCare Technologies is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Solventum 0 Very Positive mention(s) 1 Positive mention(s) 3 Neutral mention(s) 1 Negative mention(s) 1 Very Negative mention(s) Neutral GE HealthCare Technologies 9 Very Positive mention(s) 3 Positive mention(s) 6 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Which has preferable valuation and earnings, GEHC or SNN?

GE HealthCare Technologies has higher revenue and earnings than Smith & Nephew SNATS. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio GE HealthCare Technologies $20.63B 1.43 $2.08B $4.18 15.47 Smith & Nephew SNATS $6.16B 2.12 $625M N/A N/A

Does the media favor GEHC or SNN?

In the previous week, GE HealthCare Technologies had 16 more articles in the media than Smith & Nephew SNATS. MarketBeat recorded 18 mentions for GE HealthCare Technologies and 2 mentions for Smith & Nephew SNATS. GE HealthCare Technologies' average media sentiment score of 0.95 beat Smith & Nephew SNATS's score of -1.00 indicating that GE HealthCare Technologies is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment GE HealthCare Technologies 9 Very Positive mention(s) 3 Positive mention(s) 6 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Smith & Nephew SNATS 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Negative

GE HealthCare Technologies (GEHC) Competitors

$64.67 +0.86 (+1.35%)

Closing price 04:00 PM Eastern

Extended Trading

$64.25 -0.42 (-0.65%)

As of 07:59 PM Eastern

Compare

GEHC vs. PHG, MDLN, ZBH, SOLV, and SNN

Should you buy GE HealthCare Technologies stock or one of its competitors? MarketBeat compares GE HealthCare Technologies with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with GE HealthCare Technologies include Koninklijke Philips (PHG), Medline (MDLN), Zimmer Biomet (ZBH), Solventum (SOLV), and Smith & Nephew SNATS (SNN). These companies are all part of the "medical equipment" industry.

How does GE HealthCare Technologies compare to Koninklijke Philips?

GE HealthCare Technologies (NASDAQ:GEHC) and Koninklijke Philips (NYSE:PHG) are both large-cap medical companies, but which is the better business? We will compare the two businesses based on the strength of their risk, media sentiment, valuation, institutional ownership, earnings, dividends, profitability and analyst recommendations.

GE HealthCare Technologies presently has a consensus target price of $80.21, suggesting a potential upside of 24.03%. Given GE HealthCare Technologies' stronger consensus rating and higher probable upside, research analysts clearly believe GE HealthCare Technologies is more favorable than Koninklijke Philips.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
GE HealthCare Technologies	0 Sell rating(s)	9 Hold rating(s)	9 Buy rating(s)	0 Strong Buy rating(s)	2.50
Koninklijke Philips	0 Sell rating(s)	4 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00

GE HealthCare Technologies pays an annual dividend of $0.14 per share and has a dividend yield of 0.2%. Koninklijke Philips pays an annual dividend of $0.86 per share and has a dividend yield of 3.3%. GE HealthCare Technologies pays out 3.3% of its earnings in the form of a dividend. Koninklijke Philips pays out 73.5% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. GE HealthCare Technologies has raised its dividend for 1 consecutive years.

GE HealthCare Technologies has higher revenue and earnings than Koninklijke Philips. GE HealthCare Technologies is trading at a lower price-to-earnings ratio than Koninklijke Philips, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
GE HealthCare Technologies	$20.63B	1.43	$2.08B	$4.18	15.47
Koninklijke Philips	$20.17B	1.25	$1.01B	$1.17	22.33

GE HealthCare Technologies has a beta of 0.74, meaning that its share price is 26% less volatile than the broader market. Comparatively, Koninklijke Philips has a beta of 0.74, meaning that its share price is 26% less volatile than the broader market.

GE HealthCare Technologies has a net margin of 9.10% compared to Koninklijke Philips' net margin of 5.49%. GE HealthCare Technologies' return on equity of 20.46% beat Koninklijke Philips' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
GE HealthCare Technologies	9.10%	20.46%	5.73%
Koninklijke Philips	5.49%	13.51%	5.48%

In the previous week, GE HealthCare Technologies had 15 more articles in the media than Koninklijke Philips. MarketBeat recorded 18 mentions for GE HealthCare Technologies and 3 mentions for Koninklijke Philips. GE HealthCare Technologies' average media sentiment score of 0.95 beat Koninklijke Philips' score of 0.40 indicating that GE HealthCare Technologies is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
GE HealthCare Technologies	9 Very Positive mention(s)	3 Positive mention(s)	6 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Koninklijke Philips	0 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

82.1% of GE HealthCare Technologies shares are held by institutional investors. Comparatively, 13.7% of Koninklijke Philips shares are held by institutional investors. 0.4% of GE HealthCare Technologies shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Summary

GE HealthCare Technologies beats Koninklijke Philips on 16 of the 18 factors compared between the two stocks.

How does GE HealthCare Technologies compare to Medline?

Medline (NASDAQ:MDLN) and GE HealthCare Technologies (NASDAQ:GEHC) are both large-cap medical equipment companies, but which is the superior business? We will contrast the two businesses based on the strength of their institutional ownership, media sentiment, risk, profitability, analyst recommendations, valuation, earnings and dividends.

In the previous week, GE HealthCare Technologies had 8 more articles in the media than Medline. MarketBeat recorded 18 mentions for GE HealthCare Technologies and 10 mentions for Medline. GE HealthCare Technologies' average media sentiment score of 0.95 beat Medline's score of 0.22 indicating that GE HealthCare Technologies is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Medline	2 Very Positive mention(s)	3 Positive mention(s)	2 Neutral mention(s)	3 Negative mention(s)	0 Very Negative mention(s)	Neutral
GE HealthCare Technologies	9 Very Positive mention(s)	3 Positive mention(s)	6 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Medline presently has a consensus target price of $50.54, indicating a potential upside of 50.37%. GE HealthCare Technologies has a consensus target price of $80.21, indicating a potential upside of 24.03%. Given Medline's stronger consensus rating and higher probable upside, research analysts plainly believe Medline is more favorable than GE HealthCare Technologies.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Medline	1 Sell rating(s)	5 Hold rating(s)	22 Buy rating(s)	1 Strong Buy rating(s)	2.79
GE HealthCare Technologies	0 Sell rating(s)	9 Hold rating(s)	9 Buy rating(s)	0 Strong Buy rating(s)	2.50

82.1% of GE HealthCare Technologies shares are owned by institutional investors. 0.8% of Medline shares are owned by insiders. Comparatively, 0.4% of GE HealthCare Technologies shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

GE HealthCare Technologies has lower revenue, but higher earnings than Medline.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Medline	$28.43B	1.55	N/A	N/A	N/A
GE HealthCare Technologies	$20.63B	1.43	$2.08B	$4.18	15.47

GE HealthCare Technologies has a net margin of 9.10% compared to Medline's net margin of 0.00%. GE HealthCare Technologies' return on equity of 20.46% beat Medline's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Medline	N/A	N/A	N/A
GE HealthCare Technologies	9.10%	20.46%	5.73%

Summary

Medline beats GE HealthCare Technologies on 7 of the 13 factors compared between the two stocks.

How does GE HealthCare Technologies compare to Zimmer Biomet?

Zimmer Biomet (NYSE:ZBH) and GE HealthCare Technologies (NASDAQ:GEHC) are both large-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their institutional ownership, risk, media sentiment, valuation, profitability, analyst recommendations, earnings and dividends.

88.9% of Zimmer Biomet shares are held by institutional investors. Comparatively, 82.1% of GE HealthCare Technologies shares are held by institutional investors. 1.3% of Zimmer Biomet shares are held by company insiders. Comparatively, 0.4% of GE HealthCare Technologies shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

GE HealthCare Technologies has higher revenue and earnings than Zimmer Biomet. GE HealthCare Technologies is trading at a lower price-to-earnings ratio than Zimmer Biomet, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Zimmer Biomet	$8.23B	2.06	$705.20M	$3.85	22.73
GE HealthCare Technologies	$20.63B	1.43	$2.08B	$4.18	15.47

Zimmer Biomet presently has a consensus price target of $102.70, suggesting a potential upside of 17.37%. GE HealthCare Technologies has a consensus price target of $80.21, suggesting a potential upside of 24.03%. Given GE HealthCare Technologies' stronger consensus rating and higher possible upside, analysts plainly believe GE HealthCare Technologies is more favorable than Zimmer Biomet.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Zimmer Biomet	3 Sell rating(s)	12 Hold rating(s)	7 Buy rating(s)	1 Strong Buy rating(s)	2.26
GE HealthCare Technologies	0 Sell rating(s)	9 Hold rating(s)	9 Buy rating(s)	0 Strong Buy rating(s)	2.50

GE HealthCare Technologies has a net margin of 9.10% compared to Zimmer Biomet's net margin of 9.05%. GE HealthCare Technologies' return on equity of 20.46% beat Zimmer Biomet's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Zimmer Biomet	9.05%	13.24%	7.28%
GE HealthCare Technologies	9.10%	20.46%	5.73%

In the previous week, GE HealthCare Technologies had 3 more articles in the media than Zimmer Biomet. MarketBeat recorded 18 mentions for GE HealthCare Technologies and 15 mentions for Zimmer Biomet. Zimmer Biomet's average media sentiment score of 1.20 beat GE HealthCare Technologies' score of 0.95 indicating that Zimmer Biomet is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Zimmer Biomet	11 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
GE HealthCare Technologies	9 Very Positive mention(s)	3 Positive mention(s)	6 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Zimmer Biomet pays an annual dividend of $0.96 per share and has a dividend yield of 1.1%. GE HealthCare Technologies pays an annual dividend of $0.14 per share and has a dividend yield of 0.2%. Zimmer Biomet pays out 24.9% of its earnings in the form of a dividend. GE HealthCare Technologies pays out 3.3% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. GE HealthCare Technologies has raised its dividend for 1 consecutive years.

Zimmer Biomet has a beta of 0.47, meaning that its share price is 53% less volatile than the broader market. Comparatively, GE HealthCare Technologies has a beta of 0.74, meaning that its share price is 26% less volatile than the broader market.

Summary

GE HealthCare Technologies beats Zimmer Biomet on 13 of the 20 factors compared between the two stocks.

How does GE HealthCare Technologies compare to Solventum?

Solventum (NYSE:SOLV) and GE HealthCare Technologies (NASDAQ:GEHC) are both large-cap medical companies, but which is the superior investment? We will compare the two companies based on the strength of their valuation, institutional ownership, dividends, earnings, profitability, media sentiment, analyst recommendations and risk.

Solventum has a net margin of 17.33% compared to GE HealthCare Technologies' net margin of 9.10%. Solventum's return on equity of 23.51% beat GE HealthCare Technologies' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Solventum	17.33%	23.51%	7.63%
GE HealthCare Technologies	9.10%	20.46%	5.73%

In the previous week, GE HealthCare Technologies had 12 more articles in the media than Solventum. MarketBeat recorded 18 mentions for GE HealthCare Technologies and 6 mentions for Solventum. GE HealthCare Technologies' average media sentiment score of 0.95 beat Solventum's score of -0.04 indicating that GE HealthCare Technologies is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Solventum	0 Very Positive mention(s)	1 Positive mention(s)	3 Neutral mention(s)	1 Negative mention(s)	1 Very Negative mention(s)	Neutral
GE HealthCare Technologies	9 Very Positive mention(s)	3 Positive mention(s)	6 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

GE HealthCare Technologies has higher revenue and earnings than Solventum. Solventum is trading at a lower price-to-earnings ratio than GE HealthCare Technologies, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Solventum	$8.33B	1.69	$1.56B	$8.16	9.93
GE HealthCare Technologies	$20.63B	1.43	$2.08B	$4.18	15.47

82.1% of GE HealthCare Technologies shares are held by institutional investors. 0.2% of Solventum shares are held by company insiders. Comparatively, 0.4% of GE HealthCare Technologies shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Solventum has a beta of 0.69, suggesting that its share price is 31% less volatile than the broader market. Comparatively, GE HealthCare Technologies has a beta of 0.74, suggesting that its share price is 26% less volatile than the broader market.

Solventum presently has a consensus price target of $84.25, indicating a potential upside of 3.93%. GE HealthCare Technologies has a consensus price target of $80.21, indicating a potential upside of 24.03%. Given GE HealthCare Technologies' higher probable upside, analysts clearly believe GE HealthCare Technologies is more favorable than Solventum.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Solventum	1 Sell rating(s)	5 Hold rating(s)	8 Buy rating(s)	0 Strong Buy rating(s)	2.50
GE HealthCare Technologies	0 Sell rating(s)	9 Hold rating(s)	9 Buy rating(s)	0 Strong Buy rating(s)	2.50

Summary

GE HealthCare Technologies beats Solventum on 10 of the 15 factors compared between the two stocks.

How does GE HealthCare Technologies compare to Smith & Nephew SNATS?

GE HealthCare Technologies (NASDAQ:GEHC) and Smith & Nephew SNATS (NYSE:SNN) are both large-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their analyst recommendations, valuation, institutional ownership, risk, media sentiment, earnings, dividends and profitability.

GE HealthCare Technologies pays an annual dividend of $0.14 per share and has a dividend yield of 0.2%. Smith & Nephew SNATS pays an annual dividend of $0.93 per share and has a dividend yield of 3.0%. GE HealthCare Technologies pays out 3.3% of its earnings in the form of a dividend. GE HealthCare Technologies has raised its dividend for 1 consecutive years.

82.1% of GE HealthCare Technologies shares are owned by institutional investors. Comparatively, 25.6% of Smith & Nephew SNATS shares are owned by institutional investors. 0.4% of GE HealthCare Technologies shares are owned by insiders. Comparatively, 1.0% of Smith & Nephew SNATS shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

GE HealthCare Technologies has a beta of 0.74, suggesting that its share price is 26% less volatile than the broader market. Comparatively, Smith & Nephew SNATS has a beta of 0.55, suggesting that its share price is 45% less volatile than the broader market.

GE HealthCare Technologies currently has a consensus price target of $80.21, indicating a potential upside of 24.03%. Smith & Nephew SNATS has a consensus price target of $30.93, indicating a potential upside of 0.98%. Given GE HealthCare Technologies' stronger consensus rating and higher probable upside, analysts plainly believe GE HealthCare Technologies is more favorable than Smith & Nephew SNATS.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
GE HealthCare Technologies	0 Sell rating(s)	9 Hold rating(s)	9 Buy rating(s)	0 Strong Buy rating(s)	2.50
Smith & Nephew SNATS	0 Sell rating(s)	5 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.17

GE HealthCare Technologies has a net margin of 9.10% compared to Smith & Nephew SNATS's net margin of 0.00%. GE HealthCare Technologies' return on equity of 20.46% beat Smith & Nephew SNATS's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
GE HealthCare Technologies	9.10%	20.46%	5.73%
Smith & Nephew SNATS	N/A	N/A	N/A

In the previous week, GE HealthCare Technologies had 16 more articles in the media than Smith & Nephew SNATS. MarketBeat recorded 18 mentions for GE HealthCare Technologies and 2 mentions for Smith & Nephew SNATS. GE HealthCare Technologies' average media sentiment score of 0.95 beat Smith & Nephew SNATS's score of -1.00 indicating that GE HealthCare Technologies is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
GE HealthCare Technologies	9 Very Positive mention(s)	3 Positive mention(s)	6 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Smith & Nephew SNATS	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Negative

GE HealthCare Technologies has higher revenue and earnings than Smith & Nephew SNATS.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
GE HealthCare Technologies	$20.63B	1.43	$2.08B	$4.18	15.47
Smith & Nephew SNATS	$6.16B	2.12	$625M	N/A	N/A

Summary

GE HealthCare Technologies beats Smith & Nephew SNATS on 13 of the 17 factors compared between the two stocks.

Get GE HealthCare Technologies News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding GEHC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

GEHC vs. The Competition

Export

Metric	GE HealthCare Technologies	MED PRODUCTS Industry	Medical Sector	NASDAQ Exchange
Market Cap	$29.03B	$8.33B	$6.44B	$11.97B
Dividend Yield	0.22%	2.60%	2.69%	5.32%
P/E Ratio	13.99	16.14	23.77	23.66
Price / Sales	1.43	6.26	488.50	86.29
Price / Cash	10.86	17.00	41.39	55.53
Price / Book	2.84	3.56	9.76	6.39
Net Income	$2.08B	$224.05M	$3.56B	$337.36M
7 Day Performance	3.74%	-1.56%	-3.19%	-3.07%
1 Month Performance	5.95%	1.59%	-0.11%	0.37%
1 Year Performance	-9.62%	-1.05%	25.29%	27.87%

GE HealthCare Technologies Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
GEHC GE HealthCare Technologies	4.9292 of 5 stars	$64.67 +1.3%	$80.21 +24.0%	-10.3%	$29.03B	$20.63B	13.99	54,000
PHG Koninklijke Philips	2.8596 of 5 stars	$26.96 +0.0%	N/A	+13.1%	$25.95B	$20.17B	23.10	65,340
MDLN Medline	3.7699 of 5 stars	$37.01 flat	$50.85 +37.4%	N/A	$48.62B	$28.43B	N/A	43,000	Analyst Forecast High Trading Volume
ZBH Zimmer Biomet	4.5119 of 5 stars	$85.41 -0.1%	$102.80 +20.4%	-5.3%	$16.54B	$8.23B	22.19	17,000	Positive News Insider Trade
SOLV Solventum	2.1809 of 5 stars	$76.92 +0.1%	$84.25 +9.5%	+9.7%	$13.31B	$8.33B	9.43	20,000

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:GEHC) was last updated on 6/5/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

GE HealthCare Technologies (GEHC) Competitors

GEHC vs. PHG, MDLN, ZBH, SOLV, and SNN

How does GE HealthCare Technologies compare to Koninklijke Philips?

Summary

How does GE HealthCare Technologies compare to Medline?

Summary

How does GE HealthCare Technologies compare to Zimmer Biomet?

Summary

How does GE HealthCare Technologies compare to Solventum?

Summary

How does GE HealthCare Technologies compare to Smith & Nephew SNATS?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

GEHC vs. The Competition

GE HealthCare Technologies Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

GE HealthCare Technologies (GEHC) Competitors

GEHC vs. PHG, MDLN, ZBH, SOLV, and SNN

How does GE HealthCare Technologies compare to Koninklijke Philips?

Do analysts recommend GEHC or PHG?

Is GEHC or PHG a better dividend stock?

Which has better valuation and earnings, GEHC or PHG?

Which has more volatility & risk, GEHC or PHG?

Is GEHC or PHG more profitable?

Does the media favor GEHC or PHG?

Do insiders & institutionals believe in GEHC or PHG?

Summary

How does GE HealthCare Technologies compare to Medline?

Does the media refer more to MDLN or GEHC?

Do analysts recommend MDLN or GEHC?

Do insiders & institutionals have more ownership in MDLN or GEHC?

Which has higher earnings and valuation, MDLN or GEHC?

Is MDLN or GEHC more profitable?

Summary

How does GE HealthCare Technologies compare to Zimmer Biomet?

Do institutionals and insiders hold more shares of ZBH or GEHC?

Which has stronger earnings & valuation, ZBH or GEHC?

Do analysts prefer ZBH or GEHC?

Is ZBH or GEHC more profitable?

Does the media prefer ZBH or GEHC?

Is ZBH or GEHC a better dividend stock?

Which has more volatility & risk, ZBH or GEHC?

Summary

How does GE HealthCare Technologies compare to Solventum?

Is SOLV or GEHC more profitable?

Does the media refer more to SOLV or GEHC?

Which has better valuation and earnings, SOLV or GEHC?

Do insiders & institutionals believe in SOLV or GEHC?

Which has more risk and volatility, SOLV or GEHC?

Do analysts prefer SOLV or GEHC?

Summary

How does GE HealthCare Technologies compare to Smith & Nephew SNATS?

Is GEHC or SNN a better dividend stock?

Do insiders & institutionals believe in GEHC or SNN?

Which has more volatility and risk, GEHC or SNN?

Do analysts prefer GEHC or SNN?

Is GEHC or SNN more profitable?

Does the media favor GEHC or SNN?

Which has preferable valuation and earnings, GEHC or SNN?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

GEHC vs. The Competition

GE HealthCare Technologies Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools